Diadema Partners LP Biomea Fusion, Inc. Transaction History
Diadema Partners LP
- $233 Billion
- Q4 2024
A detailed history of Diadema Partners LP transactions in Biomea Fusion, Inc. stock. As of the latest transaction made, Diadema Partners LP holds 71,400 shares of BMEA stock, worth $247,044. This represents 0.12% of its overall portfolio holdings.
Number of Shares
71,400Holding current value
$247,044% of portfolio
0.12%Shares
0 transactions
| Quarter | Operation | Price Per share | shares change | shares Held | SEC Form |
|---|
Others Institutions Holding BMEA
# of Institutions
126Shares Held
17.5MCall Options Held
1.8MPut Options Held
1.08M-
Cormorant Asset Management, LP Boston, MA3.57MShares$12.4 Million1.09% of portfolio
-
Black Rock Inc. New York, NY2.34MShares$8.11 Million0.0% of portfolio
-
Baker Bros. Advisors LP New York, NY1.45MShares$5.02 Million0.06% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.4MShares$4.85 Million0.0% of portfolio
-
Aisling Capital Management LP New York, NY799KShares$2.76 Million1.14% of portfolio
About Biomea Fusion, Inc.
- Ticker BMEA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 29,290,600
- Market Cap $101M
- Description
- Biomea Fusion, Inc., a biopharmaceutical company, focuses on the discovery and development of covalent small molecule drugs to treat patients with genetically defined cancers and metabolic diseases. Its lead product candidate is BMF-219, an orally bioavailable, potent, and selective covalent inhibitor of menin, a transcriptional regulator in onc...